| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020442A1 Tumor-specific antigen peptides |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020044A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | WO2000020043A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020032A1 RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | WO2000020028A1 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 04/13/2000 | WO2000020027A2 Methods for therapeutic vaccination |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019828A1 METHODS FOR GENERATING ANTIGEN-REACTIVE T CELLS $i(IN VITRO) |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000001408A3 Haemophilus parasuis vaccine and diagnostic |
| 04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO2000000603A3 Modularly constructed rna molecules having two sequence region types |
| 04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use |
| 04/13/2000 | DE19859110A1 Bispezifische und trispezifische Antikörper, die spezifisch mit induzierbaren Oberflächenantigenen als operationelle Zielstrukturen reagieren Bispecific and tri-specific antibodies which specifically react with inducible surface antigens as operational targets |
| 04/13/2000 | CA2354863A1 Prevention of adhesions |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346864A1 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346452A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | CA2346326A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346070A1 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345817A1 Novel methods for therapeutic vaccination |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345285A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 04/13/2000 | CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344973A1 Oxidoreductase molecules |
| 04/13/2000 | CA2344765A1 Novel peptides |
| 04/13/2000 | CA2344563A1 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | CA2344552A1 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 04/13/2000 | CA2344456A1 Ptans: testis specific proteins expressed in prostate cancer |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992582A2 Schistosoma recombinant fusion protein vaccine |
| 04/12/2000 | EP0992581A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 04/12/2000 | EP0992580A2 Immunodominant human T-cell epitopes of Hepatitis C virus |
| 04/12/2000 | EP0991771A2 Lentivirus based vector and vector system |
| 04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
| 04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991758A1 Smad6 and uses thereof |
| 04/12/2000 | EP0991756A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 04/12/2000 | EP0991663A1 $i(MYCOBACTERIUM) STRAIN WITH MODIFIED $i(ERP) GENE AND VACCINE COMPOSITION CONTAINING SAME |
| 04/12/2000 | EP0991662A1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays |
| 04/12/2000 | EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 04/12/2000 | EP0991422A1 Modulating epithelial-mesenchymal interactions |
| 04/12/2000 | EP0991419A1 Treatment of infertility with leptin receptor ligands |
| 04/12/2000 | EP0991418A1 Method of modulating hypothalamic somatostatin release |
| 04/12/2000 | EP0991403A1 Use of microparticles with adsorbed antigen to stimulate immune responses |
| 04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
| 04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250478A A gene homologous to fox sperm acrosomal protein FSA-1 (CBCALD05) |
| 04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
| 04/12/2000 | CN1250380A Bovine respiratory and enteric coronavirus as a vaccine |
| 04/12/2000 | CN1250056A Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
| 04/11/2000 | US6049026 For preparing composite bone marrow graft; used to treat fractures, non-unions and to induce arthrodeses |
| 04/11/2000 | US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048715 Two-phase partition affinity separation system and affinity separated cell-containing composition |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
| 04/11/2000 | US6048700 Detecting the presence of a bordetella antigen in a sample; contacting an antibody specific antigen with said sample and detecting binding of an antibody to bordetta antigen, binding of the antbody is an indicator of presence of antigen |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048539 Immunology |
| 04/11/2000 | US6048537 Concentration, purification, fragmentation, deactivation |
| 04/11/2000 | US6048536 Vaccine compositions |
| 04/11/2000 | US6048535 Multivalent in ovo avian vaccine |
| 04/11/2000 | US6048533 Turmeric for treating health ailments |
| 04/11/2000 | US6048531 Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies |
| 04/11/2000 | US6048530 Inducing cytotoxic t-cell response against viruses, bacteria, fungi, and parasites; immunology |
| 04/11/2000 | US6048529 PVA or PEG conjugates of peptides for epitope-specific immunosuppression |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 04/11/2000 | CA1340958C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/11/2000 | CA1340956C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/06/2000 | WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | WO2000018933A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |